TYME Tyme Technologies Inc.

2.13
-0.05  -2%
Previous Close 2.18
Open 2.21
Price To Book 10.65
Market Cap 219403528
Shares 103,006,351
Volume 536,084
Short Ratio
Av. Daily Volume 1,231,849

SEC filingsSee all SEC filings

  1. 8-K - Current report 19532834
  2. 8-K - Current report 19532163
  3. 8-K - Current report 19526229
  4. 8-K - Current report 19503661
  5. S-3 - Registration statement under Securities Act of 1933 181260152

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 interim data presented January 18, 2019 noted ORR 12%.
SM-88
Pancreatic cancer
Phase 2 update due 1Q 2019.
SM-88
Prostate cancer
Phase 1/2 trial to be initiated 1Q 2019.
SM-88
Ewing’s sarcoma

SEC Filings

  1. 8-K - Current report 19532834
  2. 8-K - Current report 19532163
  3. 8-K - Current report 19526229
  4. 8-K - Current report 19503661
  5. S-3 - Registration statement under Securities Act of 1933 181260152
  6. 8-K - Current report 181175878
  7. 8-K - Current report 181158754
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 181158750
  9. 8-K - Current report 181137662
  10. 8-K - Current report 181114894